Source: Usha Resources.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Usha Resources (USHA) is pursuing a listing on the Australian Securities Exchange (ASX)
  • The company’s board believes the ASX listing will provide greater lithium project visibility in a key resources market and maximize shareholder value
  • The listing would be the company’s fourth after the TSXV, OTCQB and Frankfurt Stock Exchange
  • Vancouver-based Usha Resources is a mineral acquisition and exploration company focused on battery and precious metal properties
  • Usha (USHA) is up by 1.54 per cent, trading at $0.33 per share

Usha Resources (USHA) is pursuing a listing on the Australian Securities Exchange (ASX).

The potential listing, which would be the company’s fourth, coincides with the upcoming share distribution record date (March 24, 2023) regarding the plan of arrangement between Usha, Formation Metals and Usha shareholders.

Pursuant to the plan, Usha shareholders of record will receive one Formation share for every five Usha shares.

Usha’s board believes the ASX listing will provide greater lithium project visibility in a key resources market and maximize shareholder value as the company progresses toward development.

“We intend to tap into the significant pool of Australian investors who have been expressing interest in Usha and are looking for new investment opportunities and portfolio exposure into North America’s lithium markets,” stated Deepak Varshney, Usha’s CEO.

Vancouver-based Usha Resources is a mineral acquisition and exploration company focused on battery and precious metal properties. It holds interests in Ontario, Nevada and Arizona.

Usha (USHA) is up by 1.54 per cent, trading at $0.33 per share as of 10:10 am EST.


More From The Market Herald

" Africa Oil holding renews key oil mining license

Africa Oil holding Prime Oil & Gas has renewed oil mining license (OML) 130 in Nigeria for 20 years.
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" Next-level payment platform launches worldwide

RevoluGROUP Canada (TSXV:REVO) has launched RevoluPOS, a worldwide credit and debit card processing platform.